10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001104659-19-060500`
Period End Date	20190930
Filing Date	20191106
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	enzn-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 48 Cash Flow Statement 24 Stockholders Equity 26

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$10.02M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	-	USD	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$7.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$114.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$70.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.10M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.54M	USD	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$12.07M	USD	Point-in-time
Total assets	`Assets`	$15.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$439.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$346.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$101.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$78.00K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$5.31M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$517.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.75M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2019 and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2019 and December 31, 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2019 and December 31, 2018	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$75.69M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.63M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.32M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$12.07M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Royalties, net	`RoyaltyRevenueAndMilestones`	$2.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$-205.00K	USD	3 Qtrs
Royalties, net	`RoyaltyRevenueAndMilestones`	$-280.00K	USD	1 Quarter
Royalties, net	`RoyaltyRevenueAndMilestones`	$158.00K	USD	3 Qtrs
Total revenues	`Revenues`	$-280.00K	USD	1 Quarter
Total revenues	`Revenues`	$158.00K	USD	3 Qtrs
Total revenues	`Revenues`	$-205.00K	USD	3 Qtrs
Total revenues	`Revenues`	$2.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$826.00K	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$873.00K	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$327.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$239.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$327.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$873.00K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$826.00K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$239.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-1.03M	USD	3 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-519.00K	USD	1 Quarter
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-715.00K	USD	3 Qtrs
Operating loss and loss before income tax expense	`OperatingIncomeLoss`	$-325.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-717.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-520.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.03M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-206.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-307.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-325.00K	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	3 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	3 Qtrs
Weighted-average number of shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	3 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	3 Qtrs
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter
Weighted-average number of shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter

Cash Flow Statement 24 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.03M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-717.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-281.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-6.89M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.17M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-752.00K	USD	3 Qtrs
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	-	USD	3 Qtrs
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	$2.65M	USD	Point-in-time
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	$5.31M	USD	Point-in-time
Common stock dividend payments	`PaymentsOfDividendsCommonStock`	$2.65M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.52M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-752.00K	USD	3 Qtrs
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.02M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.02M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.50M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.48M	USD	Point-in-time
Cash end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Supplemental non-cash financing disclosure: Dividend declared in August 2019; paid in October 2019	`DividendsCommonStockCash`	-	USD	3 Qtrs
Supplemental non-cash financing disclosure: Dividend declared in August 2019; paid in October 2019	`DividendsCommonStockCash`	$5.31M	USD	3 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.11M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.84M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-717.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-520.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.03M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-21.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-371.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-206.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-307.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-325.00K	USD	1 Quarter
Common stock dividend	`DividendsCommonStockStock`	$5.31M	USD	1 Quarter
Common stock dividend	`DividendsCommonStockStock`	$2.65M	USD	1 Quarter
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.63M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.11M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.97M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.95M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.84M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.